Filing Details

Accession Number:
0001724521-25-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-27 19:06:05
Reporting Period:
2025-02-27
Filing Date:
2025-02-27
Accepted Time:
2025-02-27 19:06:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1724521 Arcus Biosciences Inc. RCUS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277503 Yasunori Kaneko C/O Arcus Biosciences, Inc.
3928 Point Eden Way
Hayward CA 94545
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-27 20,000 $10.06 28,400 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 252,524 Indirect By Kaneko Investments, LLC
Common Stock 152,981 Indirect By Trust
Common Stock 505,050 Indirect By Kaneko Capital, LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.16, inclusive. The reporting person undertakesto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at eachseparate price within the ranges set forth in this footnote.
  2. Includes 6,800 shares of restricted stock units (previously reported) that vested on June 6, 2024 and were subsequently transferred to the reporting person's trust.